What are the recent trends in market size and growth for the implantable drug delivery devices market?
The implantable drug delivery devices market size has grown strongly in recent years. It will grow from $20.65 billion in 2024 to $22.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to aging population, chronic disease prevalence, consumer awareness, growing focus on preventive healthcare, increasing demand for personalized medicine.
The implantable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $31.25 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to customized drug delivery, growing demand for minimally invasive surgeries, rising healthcare expenditure, global healthcare expansion, regenerative medicine, genomic medicine. Major trends in the forecast period include technological innovations, advancements in biotechnology, micro-implants, ai-powered dosage adjustment, telemedicine synergy, advanced biocompatible materials, advancements in drug delivery technology.
Get Your Free Sample of The Global Implantable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp
How have varous drivers impacted the growth of the implantable drug delivery devices market?
The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases, and other chronic diseases is expected to drive the implantable drug delivery devices market. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of reported TB cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases or 16%. Hence, the site-specific drug administration nature of implantable drug devices, which help in the treatment of target diseases, is driving the implantable drug delivery devices market.
What are the primary segments of the implantable drug delivery devices market?
The implantable drug delivery devices market covered in this report is segmented –
1) By Product: Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Other Applications
2) By Technology: Diffusion, Osmotic, Magnetic, Other Technologies
3) By Application: Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications
Subsegments:
1) By Contraceptive Implants: Hormonal Contraceptive Implants, Non-hormonal Contraceptive Implants
2) By Spinal Implants: Biodegradable Spinal Implants, Non-biodegradable Spinal Implants
3) By Brachytherapy Seeds: Iodine-125 Seeds, Palladium-103 Seeds, Cesium-131 Seeds, Other Brachytherapy Seeds
4) By Drug-Eluting Stents: Coronary Drug-Eluting Stents, Peripheral Drug-Eluting Stents
5) By Bio-absorbable Stents: Polymer-based Bio-absorbable Stents, Metal-based Bio-absorbable Stents
6) By Intraocular Stents: Glaucoma Intraocular Stents, Cataract Surgery Intraocular Stents
7) By Infusion Pumps: Insulin Pumps, Chemotherapy Infusion Pumps, Pain Management Infusion Pumps, Other Infusion Pumps
8) By Other Applications: Implantable Reservoirs, Implantable Micro-pumps, Implantable Drug Elution Devices
Order your report now for swift delivery
Which firms are leading the implantable drug delivery devices market?
Major companies operating in the implantable drug delivery devices market include AbbVie Inc., Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc., Merck & Co. Inc., Genentech Inc, EyePoint Pharmaceuticals Inc., DSM Biomedical, Delpor Inc., Teleflex Incorporated, 3M Company, Biotronik Inc., Alcon Inc., Terumo Corporation, Endologix Inc., TransEnterix Inc., China Grand Pharmaceutical and Healthcare Holdings, Innocoll Biotherapeutics, Atossa Therapeutics Inc., Intersect ENT, Microchips Biotech, Theradaptive Inc., CollPlant, Intarcia Therapeutics, Glaukos Corporation
What are the most influential trends expected to drive the implantable drug delivery devices market forward?
Companies and researchers are focusing on developing 3D printing material for supporting implantable drug delivery devices. 3D printing materials for drug delivery devices refer to specialized materials used in additive manufacturing processes, such as 3D printing, to create customized and precise drug delivery systems. For instance, in 2022, study published in the National Center for Biotechnology Information (NCBI) proposed the combination of 3D-printed implants and biodegradable rate-controlling membranes to produce devices capable of sustained delivery of hydrophobic drugs.
Which geographic trends are shaping the implantable drug delivery devices market, and which region has the highest market share?
North America was the largest region in the implantable drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the implantable drug delivery devices market report. The regions covered in the implantable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Implantable Drug Delivery Devices Market Report 2025 Offer?
The implantable drug delivery devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Implantable drug delivery devices are drug delivery systems implanted under the skin that transmit drugs into the bloodstream from a reservoir. These devices facilitate site-specific drug delivery and require smaller doses, thereby minimizing side effects.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3303
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
